Bedeutung des kontinuierlichen Glukosemonitorings im Diabetesmanagement – Hilfsmittel für Patienten und Arzt

Kontinuierliches Glukosemonitoring (CGM) stellt einen deutlichen Fortschritt im Diabetesmanagement dar. Vor allem Patienten mit unzureichender Stoffwechseleinstellung und starken Blutzuckerschwankungen profitieren davon, denn es hilft schwere Hypoglykämien zu vermeiden. CGM ermöglicht Patienten ihren Diabetes besser zu kontrollieren. Dem Arzt hilft es, die Ursachen von Stoffwechselinstabilitäten aufzuklären und die Effektivität der Diabetestherapie zu optimieren. CGM-Systeme sind nicht perfekt; sie sind aber der punktuellen Glukosemessung in vielerlei Hinsicht überlegen. Trotz des hohen Entwicklungsstandes weisen sie noch Unzulänglichkeiten auf. Es wäre jedoch ein Fehler, wenn die Möglichkeiten des CGM für die Optimierung der Diabetesbehandlung nicht schon heute durch eine breitere Anwendung genutzt würden. In dieser Übersicht werden bisher erzielte klinische Ergebnisse sowie Erfahrungen über die Nützlichkeit des CGM für Patienten und Arzt diskutiert.

Continuous glucose monitoring (CGM) represents a significant step forward toward modern diabetes management. It can assist in overcoming limitations of traditional glucose monitorings by providing glucose profiles over several days, real-time glucose values, glucose trends and warnings when glucose levels become dangerously low or high. Clinical studies have demonstrated that use of CGM is related to both reduced HbA_1c levels and reduced glucose variability. All types of diabetic patients will potentially benefit from CGM, especially those who depend on exogenous insulin and are thus prone to hypoglycemia. Real-time CGM systems enable patients to better control their glucose levels and prevent hypo- and hyperglycemic events. Clinicians and family physicians are enabled to reveal the causes of glycemic instability and optimize therapeutic adjustments. Current CGM systems are not perfect, but there is no doubt that they will continuously be improved. It would be a mistake to wait for improvements and not to use the current potential to optimize diabetes management. However, to use the full potential of CGM requires patient education and careful review of the data obtained. This article reviews essential clinical study outcomes and provides information on how CGM devices can best be used by both patients and care givers.

Key words

Continuous glucose monitoring - clinical study outcomes - patient benefits - physician benefits - data management reports

Literatur

• 1 Cefalu TW, Watson K. Intensive glycemic control and cardiovascular disease observations from the ACCORD study.  Diabetes. 2008;  57 1163-1165
• 2 Kohnert KD, Vogt L, Salzsieder E. Advances in understanding glucose variability and the role of continuous glucose monitoring.  European Endocrinology. 2010;  6 53-56
• 3 Diabetes Research in Children (DirecNet) Study Group . Continuous glucose monitoring in children with type 1 diabetes.  J Pediatr. 2007;  151 388-393
• 4 Garg SK, Kelly WC, Voelmle MK et al.. Continuous home monitoring of glucose: improved glycemic control with real-life use of continuous glucose sensors in adult subjects with type 1 diabetes.  Diabetes Care. 2007;  30 3023-3025
• 5 Deiss D, Bolinder J, Battelino T et al.. Improved glycemic control in poorly controlled patients with type 1 diabetes using real-time continuous glucose monitoring.  Diabetes Care. 2006;  29 2730-2732
• 6 The Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group . Continuous glucose monitoring and intensive insulin treatment of type 1 diabetes.  N Engl J Med. 2008;  359 1464-1476
• 7 Yoo HJ, An HG, Park SY et al.. Use of real time continuous glucose monitoring system as a motivational device for poorly controlled type 2 diabetes.  Diabetes Res Clin Pract. 2008;  82 73-79
• 8 Bloomgarden DK, Freeman J, DeRobertis E. Early patient and clinician experience with continuous glucose monitoring.  Diabetes Spectrum. 2008;  21 128-133
• 9 Haaß S. Trendbarometer für Zuckerwerte.  Diabetes Ratgeber. 210;  6 24-28
• 10 Vogt L, Augstein P, Kohnert KD et al.. Aus: Duesberg F, (Hrsg) E-Health 2010. Solingen: Medical Future Verlag; 2010: 190-195

Korrespondenz